CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult drug associated with AE in senior used to treat disease Topoisomerase Inhibitors [MoA] Conjunctivitis, Bacterial [Disease/Finding] Cystitis [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Escherichia coli Infections [Disease/Finding] Gonorrhea [Disease/Finding] Haemophilus Infections [Disease/Finding] Prostatitis [Disease/Finding] Pseudomonas Infections [Disease/Finding] Staphylococcal Infections [Disease/Finding] Urinary Tract Infections [Disease/Finding] Norfloxacin [Chemical/Ingredient] Decreased Protein Synthesis [PE] N [Preparations] NORFLOXACIN http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019384s060lbl.pdf <VANDF_Record>50.6^2148^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>2148</VA_IEN> C17744 N0000147623 4019503 <VANDF_Record>50.416^2117^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>2117</VA_IEN> Norfloxacin C0028365 Ingredient Active NORFLOXACIN N0F8P22L1P 7517 acute cystitis prostatitis gonorrhea headache AE asthenia AE dizziness AE nausea AE gastrointestinal cramp AE